![Scott Bizily](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 114 606 $ al 30/06/2026
Scott P.
Bizily is Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. since 2024.
Dr. Bizily was General Counsel at Synthego Corp.
from 2019 to 2021.
Dr. Bizily was Director-Corporate Counsel at BioMarin Pharmaceutical, Inc. Dr. Bizily worked at Princeton University from 1991 to 1994.
Dr. Bizily earned a doctorate from the University of Georgia in 2001 and a graduate degree from the University of Pennsylvania in 2005.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2026 | 8.617 ( 0,02 % ) | 114 606 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Oficial de Cumplimiento | 01/12/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Consejero General | 01/09/2021 |
| BIOMARIN PHARMACEUTICAL INC. | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
